Infectious Diseases (except HIV/AIDS)
-
Cov 2 MS: an automated matrix-independent assay for mass spectrometric detection and measurement of SARS-CoV-2 nucleocapsid protein in infectious patients
This article has 21 authors:Reviewed by ScreenIT
-
The REinfection in COVID‐19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers
This article has 17 authors:Reviewed by ScreenIT
-
The COVID-19 Community Research Partnership: Objectives, Study Design, Baseline Recruitment, and Retention
This article has 2 authors:Reviewed by ScreenIT
-
Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals
This article has 16 authors:Reviewed by ScreenIT
-
Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico
This article has 33 authors:Reviewed by ScreenIT
-
COVID-19 Vaccination and Estimated Public Health Impact in California
This article has 7 authors:Reviewed by ScreenIT
-
Where is Omicron? Comparison of SARS-CoV-2 RT-PCR and Antigen Test Sensitivity at Commonly Sampled Anatomic Sites Over the Course of Disease
This article has 20 authors:Reviewed by ScreenIT
-
Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial
This article has 38 authors:Reviewed by ScreenIT
-
Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study
This article has 8 authors:Reviewed by ScreenIT
-
Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection
This article has 15 authors:Reviewed by ScreenIT